Clinical Trials · NCT03179995

Trial Using Octreotide to Enhance Liver Recovery After Hepatectomy

Name: Trial Using Octreotide to Enhance Liver Recovery After Hepatectomy
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

TerminatedPhase 2Octreotide

Phase: Phase 2
Recruitment status: Terminated
Sponsor: Fox Chase Cancer Center
Enrollment: 23
Start date: Jul 2017
Locations: 2 sites, United States
Primary endpoint: Rates of Liver Recovery Will be Determined by Area Under the Curve (AUC) for Total Bilirubin and INR for Each Group

View Octreotide compound reference